Kristin Thompson is Vice President, CBO at eureKARE.
She holds a degree in Biology from the University of North Carolina-Chapel Hill and a doctorate in Molecular Medicine from the University of Ulm, Germany.
Kristin worked for more than 10 years as a researcher on projects in genetics, physiology and molecular biology for UNC-CH, Inserm in France, PTC Therapeutics and Boehringer Ingelheim.
Kristin then transitioned to roles in Business Development, including evaluation of over 1000 in- and out-licensing opportunities at the microbiome company Da Volterra in Paris, France, and as Senior Business Developer focusing on R&D and innovation with Famar. During her time managing Strategic Partnerships at Bioaster in Lyon, Kristin was also a coach for MBA students at the HEC to advise on creation of biotechs and how to build a partnering strategy. She is often consulted for strategic insights in the life science sector. Kristin is also a proactive advocate of women in synbio/deeptech.

Kristin Thompson

VP, Chief Business Officer

eureKARE

LinkedIn picto

Also speaking:

  • Elke Duwenig, Senior Biotechnology Expert Global Regulatory / Public & Government Affairs, Nutrition & Health, BASF SE
  • Michael Brandkamp, Managing Partner, European Circular Bioeconomy Fund
  • Seren Kell, Science and Technology Manager, The Good Food Institute Europe
  • Filippo Giancarlo Martinelli, Industrial Partnerships Development, Abolis Biotechnologies